Tty Biopharm Co Stock Current Valuation
| 4105 Stock | TWD 74.70 0.20 0.27% |
Valuation analysis of TTY Biopharm helps investors to measure TTY Biopharm's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that TTY Biopharm's price fluctuation is very steady at this time. Calculation of the real value of TTY Biopharm is based on 3 months time horizon. Increasing TTY Biopharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the TTY stock is determined by what a typical buyer is willing to pay for full or partial control of TTY Biopharm Co. Since TTY Biopharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TTY Stock. However, TTY Biopharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 74.7 | Real 74.35 | Hype 74.7 | Naive 74.87 |
The intrinsic value of TTY Biopharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence TTY Biopharm's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of TTY Biopharm Co helps investors to forecast how TTY stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TTY Biopharm more accurately as focusing exclusively on TTY Biopharm's fundamentals will not take into account other important factors: TTY Biopharm Co Company Current Valuation Analysis
TTY Biopharm's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current TTY Biopharm Current Valuation | 20.05 B |
Most of TTY Biopharm's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TTY Biopharm Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, TTY Biopharm Co has a Current Valuation of 20.05 B. This is 39.56% higher than that of the Healthcare sector and 169.62% higher than that of the Drug Manufacturers - Specialty & Generic industry. The current valuation for all Taiwan stocks is 20.58% lower than that of the firm.
TTY Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TTY Biopharm's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TTY Biopharm could also be used in its relative valuation, which is a method of valuing TTY Biopharm by comparing valuation metrics of similar companies.TTY Biopharm is currently under evaluation in current valuation category among its peers.
TTY Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0824 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 20.05 B | |||
| Shares Outstanding | 248.65 M | |||
| Shares Owned By Insiders | 20.58 % | |||
| Shares Owned By Institutions | 17.40 % | |||
| Price To Earning | 13.04 X | |||
| Price To Book | 3.78 X | |||
| Price To Sales | 4.10 X | |||
| Revenue | 4.54 B | |||
| Gross Profit | 2.77 B | |||
| EBITDA | 1.27 B | |||
| Net Income | 831.89 M | |||
| Cash And Equivalents | 2.89 B | |||
| Cash Per Share | 11.63 X | |||
| Total Debt | 4.15 M | |||
| Debt To Equity | 19.30 % | |||
| Current Ratio | 2.73 X | |||
| Book Value Per Share | 21.97 X | |||
| Cash Flow From Operations | 1.26 B | |||
| Earnings Per Share | 4.79 X | |||
| Target Price | 75.0 | |||
| Number Of Employees | 31 | |||
| Beta | 0.35 | |||
| Market Capitalization | 19.37 B | |||
| Total Asset | 9.3 B | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.58 % | |||
| Net Asset | 9.3 B | |||
| Last Dividend Paid | 3.0 |
About TTY Biopharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TTY Biopharm Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TTY Biopharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TTY Biopharm Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with TTY Biopharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TTY Biopharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TTY Biopharm will appreciate offsetting losses from the drop in the long position's value.Moving against TTY Stock
| 0.54 | 4746 | Formosa Laboratories | PairCorr |
| 0.45 | 4132 | Golden Biotechnology | PairCorr |
| 0.42 | 6409 | Voltronic Power Tech | PairCorr |
| 0.34 | 5274 | Aspeed Technology | PairCorr |
The ability to find closely correlated positions to TTY Biopharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TTY Biopharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TTY Biopharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TTY Biopharm Co to buy it.
The correlation of TTY Biopharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TTY Biopharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TTY Biopharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TTY Biopharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for TTY Stock Analysis
When running TTY Biopharm's price analysis, check to measure TTY Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TTY Biopharm is operating at the current time. Most of TTY Biopharm's value examination focuses on studying past and present price action to predict the probability of TTY Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TTY Biopharm's price. Additionally, you may evaluate how the addition of TTY Biopharm to your portfolios can decrease your overall portfolio volatility.